FeesSafety
Pluang+

Unitree shares soar 67% on AI breakthroughs boosting robot capabilities and JPMorgan upgrade

Market News
27 Oct 2026, 00:16 WIB
Decrypt
View Source
Bullish
Unitree shares soar 67% on AI breakthroughs boosting robot capabilities and JPMorgan upgrade

Shares of Chinese robot maker Unitree Robotics surged about 67% since mid-October, reaching a market value of 271.8 billion yuan ($40.8 billion). The rally was driven by founder Wang Xingxing's announcement that large AI models could enable significant advances in physical AI within 1-3 years, allowing robots to perform complex tasks like tidying or folding laundry. JPMorgan upgraded Unitree to overweight and raised its price target after reviewing the company's new humanoid robots and software improvements. This optimism contrasts with competitors like Tesla, which is still in early stages of robot production, highlighting Unitree's growing lead in the physical AI space.

Unitree Robotics and its AI-driven robot advancements provide context for cryptocurrency market activity on Pluang. For readers following digital assets, here is Pluang's market snapshot as of Oct 27, 2026 04:01 WIB: Of 50 major cryptocurrencies, 16 rose and 32 fell. Notable movers include BAT at Rp2.575 with a 1-day change of -6.39% and a typical hold time of 93 days, VET at Rp118 with -4.73% and 148 days hold time, and CAKE at Rp38.790 with +4.61% and 75 days hold time.

More News

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...

Company Fundamentals
Neutral
33 minutes ago
Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...

Market News
Bullish
33 minutes ago
S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions has been accepted into the SAP PartnerEdge program, marking a key milestone in its growth. This partnership enhances S4A's ability to help organizations maximize their SAP investments, especially in areas like asset management and su...

Market News
Bullish
45 minutes ago
SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

Public companies are facing new challenges for the 2027 proxy season due to changes in SEC policies, evolving shareholder activism strategies, and shifts in institutional investor voting. A virtual roundtable on October 28 will gather experts to disc...

Market News
Neutral
2 hours ago
Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo Inc., a leading provider of in-flight broadband connectivity, announced it will report its third quarter 2026 financial results on November 6, 2026, before the market opens. The company will hold a conference call with financial analysts the sam...

Company Fundamentals
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App